Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study

Publication | Open Access

DOI Full Paper Access

139

Citations

References

2018

Year

Alejandro Llanos‐Cuentas, Martín Casapía, Raúl Chuquiyauri, Juan-Carlos Hinojosa, Nicola Kerr, Maria Rosario, Stephen Toovey, Robert H. Arch, Margaret A. Phillips, Felix D. Rozenberg,

The Lancet Infectious Diseases